Literature DB >> 26762165

Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow….

Thomas Bachelet1,2, Jonathan Visentin3,4,5, Gwendaline Guidicelli3, Pierre Merville2,4,5, Lionel Couzi2,4,5, Jean-Luc Taupin6,7,8.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26762165     DOI: 10.1111/tri.12745

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


× No keyword cloud information.
  4 in total

1.  Alloimmune Risk Stratification for Kidney Transplant Rejection.

Authors:  Oriol Bestard; Olivier Thaunat; Maria Irene Bellini; Georg A Böhmig; Klemens Budde; Frans Claas; Lionel Couzi; Lucrezia Furian; Uwe Heemann; Nizam Mamode; Rainer Oberbauer; Liset Pengel; Stefan Schneeberger; Maarten Naesens
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

2.  CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.

Authors:  Chien-Chia Chen; Alice Koenig; Carole Saison; Suzan Dahdal; Guillaume Rigault; Thomas Barba; Morgan Taillardet; Dimitri Chartoire; Michel Ovize; Emmanuel Morelon; Thierry Defrance; Olivier Thaunat
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

3.  Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.

Authors:  Maria Meneghini; Edoardo Melilli; Jaume Martorell; Ignacio Revuelta; Elisabet Rigol-Monzó; Anna Manonelles; Nuria Montero; David Cucchiari; Fritz Diekmann; Josep M Cruzado; Salvador Gil-Vernet; Josep M Grinyó; Oriol Bestard
Journal:  Kidney Int Rep       Date:  2018-03-30

4.  European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group.

Authors:  Nizam Mamode; Oriol Bestard; Frans Claas; Lucrezia Furian; Siân Griffin; Christophe Legendre; Liset Pengel; Maarten Naesens
Journal:  Transpl Int       Date:  2022-08-10       Impact factor: 3.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.